Related Experiment Video

Updated: Jun 21, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Comparative in silico analyses and experimental validation of novel splice site and missense mutations in the genes

Beate Betz1, Stephan Theiss, Murat Aktas

  • 1Institut fuer Humangenetik, Universitaetsklinikum Duesseldorf, Universitaetsstrasse 1, 40225 Duesseldorf, Germany.

Journal of Cancer Research and Clinical Oncology
|August 12, 2009
PubMed

Insights

This study investigates how mutations in DNA mismatch repair genes MLH1 and MSH2 impact RNA splicing in hereditary non-polyposis colorectal cancer. Findings highlight limitations in current prediction tools for splicing alterations.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant cancer predisposition.
  • Inactivating mutations in DNA mismatch repair genes (MLH1, MSH2) are primary causes.
  • Missense mutations can disrupt protein function or alter RNA splicing.

Purpose of the Study:

  • To experimentally analyze the splicing effects of MLH1 and MSH2 mutations.
  • To evaluate the accuracy of in silico splicing prediction tools for these mutations.

Main Methods:

  • Assessed ten splice site (ss) and nine missense mutations in MLH1 and MSH2.
  • Included eleven novel mutations in the analysis.
  • Experimentally determined RNA-level effects of mutations.
  • Compared prediction accuracy of various web-based splicing outcome tools.

Main Results:

  • Experimental RNA analysis revealed splicing alterations caused by specific MLH1 and MSH2 mutations.
  • The predictive performance of tested web-based programs varied, indicating room for improvement.
  • Newly identified mutations were confirmed to affect splicing.

Conclusions:

  • Missense mutations in MLH1 and MSH2 can significantly impact RNA splicing.
  • Current computational tools have limitations in accurately predicting splicing outcomes for these mutations.
  • Further development of predictive algorithms is needed for better clinical application in HNPCC.

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.